期刊文献+

正电子发射型断层成像在胃恶性肿瘤诊断中的作用 被引量:2

Diagnostic value of positron emission tomography in gastric malignancy
下载PDF
导出
摘要 目的:评价正电子发射型断层扫描(PET)技术在胃恶性肿瘤中的诊断价值并与CT对照。方法:32例可疑胃恶性肿瘤患者术前行PET全身显像,22例行CT检查,将以上结果和病理分期对照。结果:32例中,25例为恶性肿瘤,7例为良性病变。18F-FDG-PET半定量分析对原发病灶的诊断敏感性、特异性分别为84%、5蛐7。CT对胃恶性肿瘤原发病灶诊断敏感性、特异性分别为88.9%和4蛐5。PET、CT对恶性肿瘤转移淋巴结检测准确率分别为80%和76.5%。PET、CT对远处转移病灶的诊断准确率分别为7蛐8和2蛐7。结论:PET对胃恶性肿瘤局部病灶和远处转移病灶检测较为敏感,在临床诊断有较高的应用价值。 Objective: A study was performed to evaluate the diagnostic value of positron emission tomography(PET) using 18F-fluorodeoxyglucose(FDG) in patients with gastric malignancy and correlated with computed-tomography. Methods: 32 patients suspected of gastric malignancy underwent 18F-FDG PET scan, and CT was additionally performed in 22 patients. These results were compared with the histopathological staging to evaluate the accuracy and usefulness of PET in gastric malignant tumor. Results: There are 25 malignant tumors and 7 benign diseases in the 32 patients. The sensitivity and specificity in detecting primary foci by PET was 84% and 5/7 respectively. When CT was used, the sensitivity and specificity was 88.9% and 4/5 respectively. For lymphnode metastasis PET scan was accurate in 80% compared with 76.5% from CT. The accuracy in identifying distant metastasis by PET and CT was 7/8 and 2/7 respectively. Conclusion: PET scanning is accurate and sensitive in detecting primary lesions and distant metastasis in gastric malignancy. It can provide valuable reference in the diagnosis of gastric malignancy.
机构地区 解放军总医院
出处 《中国临床医学影像杂志》 CAS 2004年第5期258-261,共4页 Journal of China Clinic Medical Imaging
基金 全军医药卫生科研基金课题(01MA095)
关键词 胃肿瘤 体层摄影术 发射型计算机 体层摄影术 X线计算机 诊断 stomach neoplasm tomography, emission-computed tomography, X-ray computed diagnosis
  • 相关文献

参考文献6

  • 1Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases: efficacy of detection with helical CT in patients with gastric cancer[J]. Radiology,1995,197:705-711.
  • 2Rice TW. Clinical staging of esophageal carcinoma.CT,EUS, and PET[J]. Chest Surg Clin North Am,2000,10(3):471-485.
  • 3De Potter T, Flamen P, Van Cutsem E, et al. Wholebody PET with FDG for the diagnosis of recurrent gastric cancer[J].Eur J Nucl Med Mol Imaging,2002,29(4):525-529.
  • 4Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis [J]. Radiology,2002,224(3):748-756.
  • 5Montravers F, Kerrou K, Grahek D, et al. Value of 18Ffluorodeoxy-glucose(FDG) positron emission topography in digestive cancerology[J]. Presse Med,2002,31(33):1560-1568.
  • 6卫勃,陈凛,田嘉禾,邵明哲,姚树林,尹大一,孔庆龙,李荣.正电子发射型断层成像技术对胃癌术前的诊断价值及临床意义[J].中华胃肠外科杂志,2003,6(3):167-170. 被引量:9

二级参考文献11

  • 1Davies J, Chalmers AG, Sue-Ling HM, et al. Spiral computed tomography and operative staging of gastric carcinoma:a comparison with histopatholagical staging. Gut, 1997, 41: 314-319.
  • 2Rice TW. Clinical staging of esophageal carcinoma. CT, EUS,and PET. Chest Surg Clin N Am,2000,10: 471-485.
  • 3Saunders CA, Dussek JE, O'Doherty M J, et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg, 1999,67: 790-797.
  • 4Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum, 2000,43: 759-770.
  • 5Burr BM, Humm JL, Kooby DA, et al. Using positron emission tomography with ^18F-FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia, 2001,3: 189-195.
  • 6Davis PW, Perrier ND, Adler L, et al. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg, 2001,67: 582-584.
  • 7Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of eosophageal cancer with ^18f-fluorodeoxyglucose positron emission tomngraphy.AJR, 1997,168: 417-424.
  • 8Bender H, Palmedo H, Biersack H J, et al. Atlas of clinical PET in ontology: PET versus CT and MRI. New York: Springer Verlag,2000. 11.
  • 9McAteer D, Wallis F, Couper G, et al. Evaluation of ^18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol, 1999,72: 525-529.
  • 10Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol, 2001,166: 825-830.

共引文献8

同被引文献24

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部